Invention Grant
- Patent Title: Cathepsin cysteine protease inhibitors
- Patent Title (中): 组织蛋白酶半胱氨酸蛋白酶抑制剂
-
Application No.: US10581692Application Date: 2004-12-09
-
Publication No.: US07687524B2Publication Date: 2010-03-30
- Inventor: Michael Boyd , Cheuk Lau , Christophe Mellon , Bruno Roy , John Scheigetz , Vouy Linh Truong
- Applicant: Michael Boyd , Cheuk Lau , Christophe Mellon , Bruno Roy , John Scheigetz , Vouy Linh Truong
- Applicant Address: CA Quebec
- Assignee: Merck Frosst Canada & Co.
- Current Assignee: Merck Frosst Canada & Co.
- Current Assignee Address: CA Quebec
- Agent Nicole M. Beeler; David A. Muthard
- International Application: PCT/CA2004/002101 WO 20041209
- International Announcement: WO2005/056529 WO 20050623
- Main IPC: A61K31/44
- IPC: A61K31/44 ; A61K31/275 ; C07D211/70 ; C07C255/46
Abstract:
This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.
Public/Granted literature
- US20070099893A1 Cathepsin cysteine protease inhibitors Public/Granted day:2007-05-03
Information query
